Asian Spectator

The Times Real Estate

.

Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020

  • Written by ACN Newswire - Press Releases

Shineway Pharmaceutical (2877.HK) recorded 29.4% revenue growth for October 2020

HONG KONG, Nov 30, 2020 - (ACN Newswire) - Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms went up 38.9%, 17.4%, 38.1%, 7.9% and 54.0% respectively.

Copyright 2020 ACN Newswire. All rights reserved. www.acnnewswire.com

Authors: ACN Newswire - Press Releases

Read more //?#

Magazine

Bahaya sering dengar musik pakai ‘earphone’: Berisiko pekak hingga depresi

● Penggunaan earphone, headphone, dan headset berlebihan bisa ganggu pendengaran dan pengaruhi kesehatan mental● Riset mengungkap mayoritas pengguna perangkat audio portabel berusia 19-29 ...

Jebakan keuangan digital: mengapa Gen Z rentan terjerat pinjol dan ‘paylater’?

●Gen Z makin mudah akses paylater, pinjol, dan investasi digital.●Banyak yang terjebak utang dan investasi spekulatif karena terpengaruh capaian orang lain di medsos.●Edukasi keuanga...

“Bayar, bayar, bayar”: Bagaimana musik dapat membentuk identitas sosial dan mendorong aksi kolektif

● Musik memiliki kekuatan untuk mempertegas identitas sosial dan memobilisasi aksi kolektif. ● Konsep ‘multiple identification’ menjelaskan bagaimana individu dapat memiliki l...